Isotope

Cambridge Isotope Laboratories (CIL) Shows Long-Term Commitment to Xenia, Ohio, Facility With New Land Purchase

Retrieved on: 
Giovedì, Aprile 25, 2024

TEWKSBURY, MA, Apr 25, 2024 - (ACN Newswire) - Cambridge Isotope Laboratories, Inc. (CIL) has acquired an additional 14.8 acres of land at its Cambridge Isotope Separations (CIS) Xenia, Ohio location.

Key Points: 
  • TEWKSBURY, MA, Apr 25, 2024 - (ACN Newswire) - Cambridge Isotope Laboratories, Inc. (CIL) has acquired an additional 14.8 acres of land at its Cambridge Isotope Separations (CIS) Xenia, Ohio location.
  • Mike Steiger, Vice President of Engineering and Project Execution for CIL, stated that the new land purchase will ensure easier access to utilities for future expansion.
  • This newly acquired land is situated to the west of the 20 acres purchased in 2017, which is currently the site of the North Star expansion project.
  • North Star is the largest 13C separation facility ever built in the world and will significantly increase CIL's capacity ensuring customer reliability for this stable isotope.

ASP Isotopes Issues Letter to Stockholders

Retrieved on: 
Giovedì, Aprile 11, 2024

WASHINGTON, April 11, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASPI,” or the “Company”), an advanced materials company dedicated to the development of technology and processes designed to produce isotopes used in multiple industries, today released the following letter to stockholders from its Chairman and CEO, Paul Mann.

Key Points: 
  • WASHINGTON, April 11, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASPI,” or the “Company”), an advanced materials company dedicated to the development of technology and processes designed to produce isotopes used in multiple industries, today released the following letter to stockholders from its Chairman and CEO, Paul Mann.
  • The contract required RC14 to provide an irrevocable standby letter of credit in lieu of a deposit, which was received.
  • Our proprietary technology has proven capabilities to enrich a wide range of isotopes, including light isotopes and lighter molecules, such as silane (SiH4).
  • ASP Isotopes’ goal is to become the lowest cost and most reliable supplier of stable isotopes globally.

Telix Pharmaceuticals Limited completes the acquisition of ARTMS, Inc.

Retrieved on: 
Giovedì, Aprile 11, 2024

ARTMS Inc. (ARTMS) is pleased to announce that the acquisition by Telix Pharmaceuticals Limited (Telix) has been completed.

Key Points: 
  • ARTMS Inc. (ARTMS) is pleased to announce that the acquisition by Telix Pharmaceuticals Limited (Telix) has been completed.
  • This acquisition further enhances the vertical integration of Telix’s supply chain and manufacturing by providing a greater level of supply chain and regulatory control over the production of key isotopes.
  • The history of ARTMS is rooted in a Canadian government funded project focused on solid target production of 99mTc.
  • Solomon Partners Securities LLC acted as financial advisor and Norton Rose Fulbright Canada LLP acted as legal advisor to ARTMS during the negotiations and due diligence process related to the acquisition by Telix.

Isobar Science: Defining Contamination Sources using Boron Isotopes

Retrieved on: 
Giovedì, Aprile 25, 2024

MIAMI, April 25, 2024 /PRNewswire/ -- Isobar Science performs high-quality boron isotope analysis in water samples for contaminant source tracking.

Key Points: 
  • MIAMI, April 25, 2024 /PRNewswire/ -- Isobar Science performs high-quality boron isotope analysis in water samples for contaminant source tracking.
  • Isobar Science uses high-quality boron isotope analysis in water for contaminant source tracking.
  • Nonpoint source pollution comes from ill-defined sources, are difficult to regulate and usually vary spatially and temporally (e.g.
  • Boron (δ11B) isotopes can provide insights into the location and source of excess nutrients entering the environment.

Acquisition of ARTMS, TRIUMF medical isotope spinoff, demonstrates value and impact of Canada's major research facilities

Retrieved on: 
Giovedì, Aprile 11, 2024

As the largest-ever acquisition of a TRIUMF spin-off company, the deal stands as a striking symbol of the role of major science facilities in driving innovation and technological breakthroughs for the benefit of Canadians.

Key Points: 
  • As the largest-ever acquisition of a TRIUMF spin-off company, the deal stands as a striking symbol of the role of major science facilities in driving innovation and technological breakthroughs for the benefit of Canadians.
  • "We turned a major global challenge into an opportunity, and today what we do is fortifying isotope supply chains and empowering research on new, life-saving medical isotopes."
  • "Canada needs major infrastructure and national communities of experts and innovators like those that exist at TRIUMF to support and launch companies like ARTMS.
  • ARTMS' story is a powerful example of what we can accomplish when we invest in fundamental science and work together."

Fossil beetles found in a Botswana diamond mine help us to reconstruct the distant past

Retrieved on: 
Mercoledì, Aprile 10, 2024

One of the few Cretaceous age deposits that’s been discovered in Africa is at Botswana’s Orapa Diamond Mine.

Key Points: 
  • One of the few Cretaceous age deposits that’s been discovered in Africa is at Botswana’s Orapa Diamond Mine.
  • Recently a team I lead discovered two new species of rove beetles preserved in the sediments of the Orapa Diamond Mine.
  • Rove beetles are typically identified by their unique short elytra (protective wing cases) which expose the rest of the abdomen.
  • Our finds are the first fossil rove beetles ever discovered on the continent and in the southern hemisphere.
  • The fossils closely resemble today’s rove beetles, showing how successful they’ve been in adapting to various environments without significant changes to their bodies.

Identifying the fossils

  • We found the fossils in lacustrine sediments (deposits that accumulate in lake environments).
  • Afristenus orapensis belongs to the stenine rove beetle subgroup while Paleothius mckayi belongs to the subgroup staphylinine.
  • The stenine rove beetle was previously described in Russia, France and Myanmar while the staphylinine rove beetle was previously described in Russia, China, Myanmar and England.
  • So we scoured research articles about fossils of a similar age that have already been studied elsewhere for comparative purposes.

More to find

  • We are currently studying each specimen and preparing academic manuscripts that describe what we’ve found.
  • My hope is that more money will be invested in training more palaeoentomologists in South Africa and on the continent more broadly.
  • The study of fossil insects and plants is an important way to preserve our beloved continent’s heritage.


Sandiso Mnguni receives funding from GENUS (Centre of Excellence in Palaeosciences - UID 86073). He is affiliated with the Sophumelela Youth Development Programme (SYDP).

Cambridge Isotope Laboratories, Inc. (CIL) Announces Relocation of Corporate Headquarters and Expansion of Research & Development and cGMP Production

Retrieved on: 
Venerdì, Marzo 15, 2024

The new location is a two-building, 150,000-square-foot campus with 25 lakefront acres at 100 & 200 Ames Pond Drive.

Key Points: 
  • The new location is a two-building, 150,000-square-foot campus with 25 lakefront acres at 100 & 200 Ames Pond Drive.
  • The Ames Pond campus will be the home of a new 8,000-square-foot research and development (R&D) facility and will significantly expand cGMP, QC, formulations, and production labs.
  • This expansion provides CIL the space to develop new products and invest in advanced analytical and production technologies," states CIL's Chief Science Officer (CSO) Todd Osiek.
  • CIL will continue operating its existing headquarters at 3 Highwood Drive, Tewksbury, MA, and production facility located 50 Frontage Road in Andover, MA.

ASP Isotopes Inc. Enters Into Warrant Inducement Transaction for Approximately $5.5 Million in Gross Proceeds

Retrieved on: 
Martedì, Aprile 9, 2024

The Company believes the structure of this transaction will result in substantially less fees, costs and dilution than may occur in other capital raising transactions, such as an underwritten offering of common stock or a private placement priced at a discount.

Key Points: 
  • The Company believes the structure of this transaction will result in substantially less fees, costs and dilution than may occur in other capital raising transactions, such as an underwritten offering of common stock or a private placement priced at a discount.
  • “We took the opportunity to do this transaction because we view it as an attractive means of raising additional capital; $5.5 million for 1.225 million new warrants is effectively $4.50 per share with minimal transaction costs,” said Paul Mann, Chairman and CEO of ASP Isotopes.
  • The offering is expected to close on or about April 11, 2024.
  • The Company has agreed to file a registration statement with the SEC covering the resale of common shares issuable upon exercise of the New Warrants.

LIS Technologies Inc. Officially Joins the World Nuclear Association, a Global Advocate for the Nuclear Industry

Retrieved on: 
Martedì, Aprile 9, 2024

Figure 1 - LIS Technologies Inc.

Key Points: 
  • Figure 1 - LIS Technologies Inc.
  • Joins the World Nuclear Association (“WNA”)
    The World Nuclear Association’s mission is to promote a wider understanding of nuclear energy among key international influencers by producing authoritative information, developing common industry positions, and contributing to the energy debate.
  • It is the only industry organization with a global mandate to promote nuclear energy and is in a unique position to share and advance best practice and common messages globally.
  • The Association provides a forum for industry collaboration, supports the development of nuclear technologies, and works to ensure high standards of safety and excellence within the nuclear field and is committed to fostering growth and innovation in the nuclear industry, ensuring a clean, secure, and prosperous energy future.

ASP Isotopes Inc. Enters Into a Contract with U.S.-Based Small Modular Reactor (SMR) Company for Project Focused on Engineering Design and Planning for Enrichment Facility for the Production of Advanced Nuclear Fuels

Retrieved on: 
Lunedì, Aprile 8, 2024

The advanced nuclear fuels required during the next fifty years are expected to differ significantly from those used in the last fifty years.

Key Points: 
  • The advanced nuclear fuels required during the next fifty years are expected to differ significantly from those used in the last fifty years.
  • Without these advanced nuclear fuels, the world stands little chance of meeting 2050 climate goals.
  • Specifically, many SMRs in the future will require HALEU (High Assay Low Enriched Uranium) and nuclear fusion will require Lithium-6.
  • To meet 2050 climate goals, this must occur with a zero increase in carbon emissions.